nodes	percent_of_prediction	percent_of_DWPC	metapath
Lorazepam—Obstructive airways disorder—Methotrexate—ankylosing spondylitis	0.0264	0.0264	CcSEcCtD
Lorazepam—Pericardial effusion—Methotrexate—ankylosing spondylitis	0.0146	0.0146	CcSEcCtD
Lorazepam—Suicidal ideation—Methylprednisolone—ankylosing spondylitis	0.0129	0.0129	CcSEcCtD
Lorazepam—Mania—Methylprednisolone—ankylosing spondylitis	0.0125	0.0125	CcSEcCtD
Lorazepam—Suicidal ideation—Betamethasone—ankylosing spondylitis	0.0118	0.0118	CcSEcCtD
Lorazepam—Suicidal ideation—Dexamethasone—ankylosing spondylitis	0.0118	0.0118	CcSEcCtD
Lorazepam—Mania—Dexamethasone—ankylosing spondylitis	0.0113	0.0113	CcSEcCtD
Lorazepam—Mania—Betamethasone—ankylosing spondylitis	0.0113	0.0113	CcSEcCtD
Lorazepam—Suicidal ideation—Prednisone—ankylosing spondylitis	0.0102	0.0102	CcSEcCtD
Lorazepam—Mania—Prednisone—ankylosing spondylitis	0.00987	0.00987	CcSEcCtD
Lorazepam—Leukocytosis—Methylprednisolone—ankylosing spondylitis	0.00965	0.00965	CcSEcCtD
Lorazepam—Hypoxia—Methotrexate—ankylosing spondylitis	0.00945	0.00945	CcSEcCtD
Lorazepam—Memory impairment—Prednisone—ankylosing spondylitis	0.00915	0.00915	CcSEcCtD
Lorazepam—Pulmonary oedema—Prednisolone—ankylosing spondylitis	0.0088	0.0088	CcSEcCtD
Lorazepam—Leukocytosis—Dexamethasone—ankylosing spondylitis	0.00877	0.00877	CcSEcCtD
Lorazepam—Leukocytosis—Betamethasone—ankylosing spondylitis	0.00877	0.00877	CcSEcCtD
Lorazepam—Paralysis—Methotrexate—ankylosing spondylitis	0.00864	0.00864	CcSEcCtD
Lorazepam—Euphoric mood—Prednisolone—ankylosing spondylitis	0.00849	0.00849	CcSEcCtD
Lorazepam—Delirium—Prednisone—ankylosing spondylitis	0.00835	0.00835	CcSEcCtD
Lorazepam—Pulmonary oedema—Triamcinolone—ankylosing spondylitis	0.00809	0.00809	CcSEcCtD
Lorazepam—Pulmonary oedema—Methylprednisolone—ankylosing spondylitis	0.00807	0.00807	CcSEcCtD
Lorazepam—Stupor—Methotrexate—ankylosing spondylitis	0.00804	0.00804	CcSEcCtD
Lorazepam—Euphoric mood—Triamcinolone—ankylosing spondylitis	0.00781	0.00781	CcSEcCtD
Lorazepam—Euphoric mood—Methylprednisolone—ankylosing spondylitis	0.00779	0.00779	CcSEcCtD
Lorazepam—Leukocytosis—Prednisone—ankylosing spondylitis	0.00764	0.00764	CcSEcCtD
Lorazepam—Visual disturbance—Prednisolone—ankylosing spondylitis	0.00757	0.00757	CcSEcCtD
Lorazepam—Blood alkaline phosphatase increased—Methylprednisolone—ankylosing spondylitis	0.00757	0.00757	CcSEcCtD
Lorazepam—Pulmonary oedema—Betamethasone—ankylosing spondylitis	0.00734	0.00734	CcSEcCtD
Lorazepam—Pulmonary oedema—Dexamethasone—ankylosing spondylitis	0.00734	0.00734	CcSEcCtD
Lorazepam—Osteoarthritis—Prednisolone—ankylosing spondylitis	0.00717	0.00717	CcSEcCtD
Lorazepam—Euphoric mood—Betamethasone—ankylosing spondylitis	0.00708	0.00708	CcSEcCtD
Lorazepam—Euphoric mood—Dexamethasone—ankylosing spondylitis	0.00708	0.00708	CcSEcCtD
Lorazepam—Apnoea—Methotrexate—ankylosing spondylitis	0.00708	0.00708	CcSEcCtD
Lorazepam—Amnesia—Methylprednisolone—ankylosing spondylitis	0.00701	0.00701	CcSEcCtD
Lorazepam—Cardiac arrest—Prednisolone—ankylosing spondylitis	0.00682	0.00682	CcSEcCtD
Lorazepam—Osteoarthritis—Triamcinolone—ankylosing spondylitis	0.0066	0.0066	CcSEcCtD
Lorazepam—Osteoarthritis—Methylprednisolone—ankylosing spondylitis	0.00658	0.00658	CcSEcCtD
Lorazepam—Psychotic disorder—Methylprednisolone—ankylosing spondylitis	0.00643	0.00643	CcSEcCtD
Lorazepam—Pulmonary oedema—Prednisone—ankylosing spondylitis	0.00639	0.00639	CcSEcCtD
Lorazepam—Dysarthria—Methotrexate—ankylosing spondylitis	0.00634	0.00634	CcSEcCtD
Lorazepam—Visual disturbance—Dexamethasone—ankylosing spondylitis	0.00632	0.00632	CcSEcCtD
Lorazepam—Visual disturbance—Betamethasone—ankylosing spondylitis	0.00632	0.00632	CcSEcCtD
Lorazepam—Irritability—Methylprednisolone—ankylosing spondylitis	0.00628	0.00628	CcSEcCtD
Lorazepam—Cardiac arrest—Triamcinolone—ankylosing spondylitis	0.00627	0.00627	CcSEcCtD
Lorazepam—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	0.00626	0.00626	CcSEcCtD
Lorazepam—Euphoric mood—Prednisone—ankylosing spondylitis	0.00617	0.00617	CcSEcCtD
Lorazepam—Respiratory failure—Methotrexate—ankylosing spondylitis	0.00611	0.00611	CcSEcCtD
Lorazepam—Lethargy—Dexamethasone—ankylosing spondylitis	0.00611	0.00611	CcSEcCtD
Lorazepam—Lethargy—Betamethasone—ankylosing spondylitis	0.00611	0.00611	CcSEcCtD
Lorazepam—Osteoarthritis—Betamethasone—ankylosing spondylitis	0.00599	0.00599	CcSEcCtD
Lorazepam—Osteoarthritis—Dexamethasone—ankylosing spondylitis	0.00599	0.00599	CcSEcCtD
Lorazepam—Cystitis noninfective—Methotrexate—ankylosing spondylitis	0.00586	0.00586	CcSEcCtD
Lorazepam—Psychotic disorder—Dexamethasone—ankylosing spondylitis	0.00585	0.00585	CcSEcCtD
Lorazepam—Psychotic disorder—Betamethasone—ankylosing spondylitis	0.00585	0.00585	CcSEcCtD
Lorazepam—Depressed level of consciousness—Methotrexate—ankylosing spondylitis	0.00579	0.00579	CcSEcCtD
Lorazepam—Cystitis—Methotrexate—ankylosing spondylitis	0.00579	0.00579	CcSEcCtD
Lorazepam—Irritability—Betamethasone—ankylosing spondylitis	0.00571	0.00571	CcSEcCtD
Lorazepam—Irritability—Dexamethasone—ankylosing spondylitis	0.00571	0.00571	CcSEcCtD
Lorazepam—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.00569	0.00569	CcSEcCtD
Lorazepam—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.00569	0.00569	CcSEcCtD
Lorazepam—Amnesia—Prednisone—ankylosing spondylitis	0.00555	0.00555	CcSEcCtD
Lorazepam—Coma—Methotrexate—ankylosing spondylitis	0.00548	0.00548	CcSEcCtD
Lorazepam—Bladder pain—Methotrexate—ankylosing spondylitis	0.00543	0.00543	CcSEcCtD
Lorazepam—Pulmonary oedema—Methotrexate—ankylosing spondylitis	0.00534	0.00534	CcSEcCtD
Lorazepam—Lethargy—Prednisone—ankylosing spondylitis	0.00532	0.00532	CcSEcCtD
Lorazepam—Osteoarthritis—Prednisone—ankylosing spondylitis	0.00521	0.00521	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Prednisone—ankylosing spondylitis	0.00521	0.00521	CcSEcCtD
Lorazepam—Psychotic disorder—Prednisone—ankylosing spondylitis	0.00509	0.00509	CcSEcCtD
Lorazepam—Bradycardia—Prednisolone—ankylosing spondylitis	0.00505	0.00505	CcSEcCtD
Lorazepam—Irritability—Prednisone—ankylosing spondylitis	0.00497	0.00497	CcSEcCtD
Lorazepam—Cardiac arrest—Prednisone—ankylosing spondylitis	0.00496	0.00496	CcSEcCtD
Lorazepam—Visual impairment—Prednisolone—ankylosing spondylitis	0.00478	0.00478	CcSEcCtD
Lorazepam—Bradycardia—Triamcinolone—ankylosing spondylitis	0.00465	0.00465	CcSEcCtD
Lorazepam—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00464	0.00464	CcSEcCtD
Lorazepam—Visual disturbance—Methotrexate—ankylosing spondylitis	0.0046	0.0046	CcSEcCtD
Lorazepam—Hallucination—Methylprednisolone—ankylosing spondylitis	0.00453	0.00453	CcSEcCtD
Lorazepam—Lethargy—Methotrexate—ankylosing spondylitis	0.00445	0.00445	CcSEcCtD
Lorazepam—Arrhythmia—Prednisolone—ankylosing spondylitis	0.00443	0.00443	CcSEcCtD
Lorazepam—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.00439	0.00439	CcSEcCtD
Lorazepam—Osteoarthritis—Methotrexate—ankylosing spondylitis	0.00436	0.00436	CcSEcCtD
Lorazepam—Erythema—Prednisolone—ankylosing spondylitis	0.00432	0.00432	CcSEcCtD
Lorazepam—Bradycardia—Betamethasone—ankylosing spondylitis	0.00422	0.00422	CcSEcCtD
Lorazepam—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00422	0.00422	CcSEcCtD
Lorazepam—Irritability—Methotrexate—ankylosing spondylitis	0.00416	0.00416	CcSEcCtD
Lorazepam—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.00415	0.00415	CcSEcCtD
Lorazepam—Hallucination—Dexamethasone—ankylosing spondylitis	0.00412	0.00412	CcSEcCtD
Lorazepam—Hallucination—Betamethasone—ankylosing spondylitis	0.00412	0.00412	CcSEcCtD
Lorazepam—Ataxia—Methotrexate—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Lorazepam—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00408	0.00408	CcSEcCtD
Lorazepam—Vision blurred—Prednisolone—ankylosing spondylitis	0.00407	0.00407	CcSEcCtD
Lorazepam—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00407	0.00407	CcSEcCtD
Lorazepam—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.00402	0.00402	CcSEcCtD
Lorazepam—Visual impairment—Dexamethasone—ankylosing spondylitis	0.00399	0.00399	CcSEcCtD
Lorazepam—Visual impairment—Betamethasone—ankylosing spondylitis	0.00399	0.00399	CcSEcCtD
Lorazepam—Erythema—Triamcinolone—ankylosing spondylitis	0.00397	0.00397	CcSEcCtD
Lorazepam—Erythema—Methylprednisolone—ankylosing spondylitis	0.00396	0.00396	CcSEcCtD
Lorazepam—Vertigo—Prednisolone—ankylosing spondylitis	0.00388	0.00388	CcSEcCtD
Lorazepam—Convulsion—Prednisolone—ankylosing spondylitis	0.00374	0.00374	CcSEcCtD
Lorazepam—Hypertension—Prednisolone—ankylosing spondylitis	0.00373	0.00373	CcSEcCtD
Lorazepam—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.0037	0.0037	CcSEcCtD
Lorazepam—Arrhythmia—Betamethasone—ankylosing spondylitis	0.0037	0.0037	CcSEcCtD
Lorazepam—Bradycardia—Prednisone—ankylosing spondylitis	0.00367	0.00367	CcSEcCtD
Lorazepam—Alopecia—Dexamethasone—ankylosing spondylitis	0.00366	0.00366	CcSEcCtD
Lorazepam—Alopecia—Betamethasone—ankylosing spondylitis	0.00366	0.00366	CcSEcCtD
Lorazepam—Erythema—Dexamethasone—ankylosing spondylitis	0.0036	0.0036	CcSEcCtD
Lorazepam—Erythema—Betamethasone—ankylosing spondylitis	0.0036	0.0036	CcSEcCtD
Lorazepam—Hallucination—Prednisone—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Lorazepam—Pancytopenia—Methotrexate—ankylosing spondylitis	0.00358	0.00358	CcSEcCtD
Lorazepam—Vertigo—Triamcinolone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Lorazepam—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Lorazepam—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00347	0.00347	CcSEcCtD
Lorazepam—Convulsion—Triamcinolone—ankylosing spondylitis	0.00344	0.00344	CcSEcCtD
Lorazepam—Tachycardia—Prednisolone—ankylosing spondylitis	0.00344	0.00344	CcSEcCtD
Lorazepam—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00343	0.00343	CcSEcCtD
Lorazepam—Hypertension—Triamcinolone—ankylosing spondylitis	0.00343	0.00343	CcSEcCtD
Lorazepam—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00342	0.00342	CcSEcCtD
Lorazepam—Drowsiness—Methotrexate—ankylosing spondylitis	0.00336	0.00336	CcSEcCtD
Lorazepam—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00331	0.00331	CcSEcCtD
Lorazepam—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00326	0.00326	CcSEcCtD
Lorazepam—Vertigo—Dexamethasone—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Lorazepam—Vertigo—Betamethasone—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Lorazepam—Arrhythmia—Prednisone—ankylosing spondylitis	0.00322	0.00322	CcSEcCtD
Lorazepam—Infection—Triamcinolone—ankylosing spondylitis	0.00322	0.00322	CcSEcCtD
Lorazepam—Infection—Methylprednisolone—ankylosing spondylitis	0.00321	0.00321	CcSEcCtD
Lorazepam—Alopecia—Prednisone—ankylosing spondylitis	0.00319	0.00319	CcSEcCtD
Lorazepam—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00316	0.00316	CcSEcCtD
Lorazepam—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00316	0.00316	CcSEcCtD
Lorazepam—Erythema—Prednisone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Lorazepam—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Lorazepam—Convulsion—Betamethasone—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Lorazepam—Convulsion—Dexamethasone—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Lorazepam—Hypertension—Betamethasone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Lorazepam—Hypertension—Dexamethasone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Lorazepam—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Lorazepam—Pain—Prednisolone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Lorazepam—Vision blurred—Prednisone—ankylosing spondylitis	0.00296	0.00296	CcSEcCtD
Lorazepam—Infection—Betamethasone—ankylosing spondylitis	0.00292	0.00292	CcSEcCtD
Lorazepam—Infection—Dexamethasone—ankylosing spondylitis	0.00292	0.00292	CcSEcCtD
Lorazepam—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Lorazepam—Visual impairment—Methotrexate—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Lorazepam—Agitation—Prednisone—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Lorazepam—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Lorazepam—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Lorazepam—Tachycardia—Betamethasone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Lorazepam—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Lorazepam—Vertigo—Prednisone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Lorazepam—Fatigue—Triamcinolone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Lorazepam—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00279	0.00279	CcSEcCtD
Lorazepam—Pain—Triamcinolone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Lorazepam—Hypotension—Betamethasone—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Lorazepam—Hypotension—Dexamethasone—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Lorazepam—Convulsion—Prednisone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Lorazepam—Hypertension—Prednisone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Lorazepam—Chills—Methotrexate—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Lorazepam—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Lorazepam—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Lorazepam—Alopecia—Methotrexate—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Lorazepam—Erythema—Methotrexate—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Lorazepam—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Lorazepam—Infection—Prednisone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Lorazepam—Fatigue—Dexamethasone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Lorazepam—Fatigue—Betamethasone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Lorazepam—Pain—Betamethasone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Lorazepam—Pain—Dexamethasone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Lorazepam—Tachycardia—Prednisone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Lorazepam—Vision blurred—Methotrexate—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Lorazepam—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Lorazepam—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Lorazepam—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Lorazepam—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Lorazepam—Vertigo—Methotrexate—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Lorazepam—Dizziness—Prednisolone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Lorazepam—Asthenia—Triamcinolone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Lorazepam—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Lorazepam—Convulsion—Methotrexate—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Lorazepam—Rash—Prednisolone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Lorazepam—Dermatitis—Prednisolone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Lorazepam—Fatigue—Prednisone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Lorazepam—Headache—Prednisolone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Lorazepam—Constipation—Prednisone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Lorazepam—Confusional state—Methotrexate—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Lorazepam—Dizziness—Triamcinolone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Lorazepam—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Lorazepam—Infection—Methotrexate—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Lorazepam—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Lorazepam—Asthenia—Betamethasone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Lorazepam—Asthenia—Dexamethasone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Lorazepam—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Lorazepam—Nausea—Prednisolone—ankylosing spondylitis	0.00209	0.00209	CcSEcCtD
Lorazepam—Vomiting—Triamcinolone—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Lorazepam—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Lorazepam—Rash—Triamcinolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Lorazepam—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Lorazepam—Rash—Methylprednisolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Lorazepam—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Lorazepam—Headache—Triamcinolone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Lorazepam—Headache—Methylprednisolone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Lorazepam—Hypotension—Methotrexate—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Lorazepam—Dizziness—Betamethasone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Lorazepam—Dizziness—Dexamethasone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Lorazepam—Nausea—Triamcinolone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Lorazepam—Nausea—Methylprednisolone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Lorazepam—Somnolence—Methotrexate—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Lorazepam—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Lorazepam—Vomiting—Betamethasone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Lorazepam—Vomiting—Dexamethasone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Lorazepam—Rash—Dexamethasone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Lorazepam—Rash—Betamethasone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Lorazepam—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Lorazepam—Dermatitis—Betamethasone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Lorazepam—Fatigue—Methotrexate—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Lorazepam—Headache—Betamethasone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Lorazepam—Headache—Dexamethasone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Lorazepam—Asthenia—Prednisone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Lorazepam—Pain—Methotrexate—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Lorazepam—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Lorazepam—Nausea—Dexamethasone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Lorazepam—Nausea—Betamethasone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Lorazepam—Dizziness—Prednisone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Lorazepam—Vomiting—Prednisone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Lorazepam—Rash—Prednisone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Lorazepam—Dermatitis—Prednisone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Lorazepam—Headache—Prednisone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Lorazepam—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Lorazepam—Asthenia—Methotrexate—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Lorazepam—Nausea—Prednisone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Lorazepam—Dizziness—Methotrexate—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Lorazepam—Vomiting—Methotrexate—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Lorazepam—Rash—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Lorazepam—Dermatitis—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Lorazepam—Headache—Methotrexate—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Lorazepam—Nausea—Methotrexate—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
